F. Korell - Hematol, Oncol,Rheumatol, Univ Hosp Heidelberg

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

56P Multi-omic Profiling in Cholangiocarcinoma to Enable Scientific Advancement Within the DKFZ/NCT/DKTK MASTER Study

F. Nichetti,F. Korell, M. Schwab, P.K.M. Hoffmeister,J. Hüllein,S. Uhrig,M-V. Teleanu,S. Kreutzfeldt, P. Horak, H. Glimm,C. Heining,D.T. Rieke, T. Kindler,D. Hübschmann,C. Springfeld, M. Jenzer,C.E. Heilig,S. Fröhling, B.C. Köhler

Annals of Oncology (2024)

引用0浏览0引用

3RD-GENERATION CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELLS (CARTS) FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - UPDATE ON THE ONGOING ACADEMIC PHASE 1/2 TRIAL (HD-CAR-1)

P. Derigs,A. Kunz,P. Dreger,A. Schmitt,M. -L. Schubert,M. Brueggemann,H. Bernhard,G. Kobbe,A. Lindemann,M. Rummel,L. Wang,B. Michels,P. Waldhoff,F. Korell,S. Laier,A. D. Ho,C. Mueller-Tidow,M. Schmitt

HUMAN GENE THERAPYno. 21-22 (2023): A7-A8

引用0浏览0引用

Absence of CD39 on Chimeric Antigen Receptor (CAR) T Cells is Predictive for Response in Adult ALL Patients

M. L. Schubert,A. Schmitt, A. Huckelhoven-Krauss,B. Neuber, P. Waldho,D. Vonficht,S. Yousefian, L. Jopp-Saile,F. Korell, S. Haas,A. D. Ho,C. Mueller-Tidow,P. Dreger,M. Schmitt

ONCOLOGY RESEARCH AND TREATMENT (2023): 37-37

引用0浏览0引用

Robust prediction model for steroid refractory/resistant acute GvHD based on HLA-DR and CD62L expression

Y. Ding,A. Schmitt,M. Ni,F. Korell, A. Keib,M. -L. Schubert,T. Sauer,P. Derigs,B. Neuber, A. H. Krauss,T. Luft,U. Hegenbart,S. Schoenland,V. Eckstein,W. Krueger,R. Yerushalmi,K. Beider,A. Nagler, C. M. Tidow,P. Dreger,M. Schmitt, L. Wang

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 238-239

引用0浏览0引用

Third Generation CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells for Relapsed or Refractory Chronic Lymphocytic Leukemia - Update of the Ongoing Academic Phase 1/2 Trial (HD-CAR-1)

P. Derigs,A. Kunz,P. Dreger,A. Schmitt,M. -L. Schubert,M. Bruggemann,H. Bernhard,G. Kobbe,A. Lindemann,M. Rummel,L. Wang,B. Michels,P. Waldhoff,F. Korell,S. Laier,A. D. Ho,C. Muller-Tidow,M. Schmitt

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 41-42

引用0浏览0引用

Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR

N. Schanda,A. Kunz,T. Sauer,M. -L Schubert,F. Korell,A. Hueckelhoven-Krauss,B. Neuber,M. Hinkelbein,C. Mueller-Tidow,M. Schmitt,A. Schmitt

Cells（2021）

引用11浏览0WOS引用

Infection complications after lymphodepletion and dosing of Chimeric antigen receptor T (CAR-T) cell therapy - a six-month follow-up

F. Korell,M. L. Schubert,T. Sauer,A. Schmitt,P. Derigs,T. F. Weber,P. Schnitzler,C. Mueller-Tidow,P. Dreger,M. Schmitt

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

EASIX to Predict Complications and Outcome in Patients Receiving CAR-T Cell Therapy

F. Korell,M. Schmitt,A. Schmitt,M. -L. Schubert,C. Mueller-Tidow,P. Dreger,T. Luft

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 4 (2020): 193-193

引用0浏览0引用

Manufacturing of CAR-T Cells for Patients with Relapsed/refractory ALL or NHL Requires Good Leukapheresis Products

F. Korell,S. Laier,S. Sauer,K. Veelken, H. Hennemann,M. -L Schubert,T. Sauer,P. Pavel,C. Mueller-Tidow,P. Dreger,M. Schmitt,A. Schmitt

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 4 (2020): 196-196

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn